Company: JACS-RI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001213900-25-107171
Chunk: 28

Company: Jackson Acquisition Co II
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 28
---

    2024 
  
    Cash 
    $585,116  
    $949,366 
  
    Marketable securities held in Trust Account 
    $240,215,212  
    $232,858,478 

    For the Three Months Ended September 30, 2025  
    For the Nine months Ended September 30, 2025  
    For the Period from September 11, 2024 (Inception) Through September 30, 2024 
  
    General and administrative expenses 
    $129,619  
    $464,977  
    $49,568 
  
    Interest earned on marketable securities held in Trust Account 
    $2,475,639  
    $7,356,734  
    $— 

The CODM reviews interest earned on marketable
securities held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with
the Trust Account funds while maintaining compliance with the Trust Agreement.

General and administrative expenses are reviewed
and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar
transaction within the Combination Period. The CODM also reviews general and administrative expenses to manage, maintain and enforce all
contractual agreements to ensure costs are aligned with all agreements and budget. general and administrative expenses, as reported on
the condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

NOTE 10 — SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions
that occurred after the condensed balance sheet date through the date that the condensed financial statements were issued. Based upon
this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial
statements.

18

Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.

References in this report (this “Quarterly
Report”) to “we,” “us” or the “Company” refer to Jackson Acquisition Company II. References
to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor”
refer to RJ Healthcare SPAC II, LLC. The following discussion and analysis of the Company’s financial condition and results of operations
should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly
Report. Certain information contained in